Department of Clinical Sciences, Medical Faculty, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.
Anaesthesiol Intensive Ther. 2021;53(5):390-397. doi: 10.5114/ait.2021.111739.
Previous studies have demonstrated that low-grade red blood cell transfusions (RBC) given to septic patients are harmful. The objectives of the present study were to compare mortality and morbidity in non-septic critically ill patients who were given low-grade RBC transfusions at haemoglobin level > 70 γ L-1 with patients without RBC-transfusions any of the first 5 days in intensive care.
Adult patients admitted to a general intensive care unit between 2007 and 2018 at a university hospital were eligible for inclusion. Patients who received > 2 units RBC transfusion per day during the first 5 days after admisasion, with pre-transfusion haemoglobin level < 70 γ L-1 or with severe sepsis or septic shock, were excluded.
In total, 9491 admissions were recorded during the study period. Propensity score matching resulted in 2 well matched groups with 674 unique patients in each. Median pre-transfusion haemoglobin was 98 γ L-1 (interquartile range 91-107 γ L-1). Mortality was higher in the RBC group with an absolute risk increase for death at 180 days of 5.9% (95% CI: 3.6-8.3; P < 0.001). Low-grade RBC-transfusion was also associated with renal, circulatory, and respiratory failure as well as a higher SOFA-max score. Sensitivity analyses suggested that disease trajectories during the exposure time did not significantly differ between the groups.
Low-grade RBC-transfusions given to non-septic critically ill patients without significant anaemia were associated with increased mortality, increased kidney, circulatory, and respiratory failure, as well as higher SOFA-max score.
先前的研究表明,给脓毒症患者输注低剂量红细胞(RBC)是有害的。本研究的目的是比较血红蛋白水平> 70 γ L-1的非脓毒症危重症患者在第 1 天至第 5 天内输注低剂量 RBC 与无任何 RBC 输注的患者的死亡率和发病率在重症监护室。
符合条件的患者为 2007 年至 2018 年期间在一家大学医院普通重症监护病房住院的成年患者。排除了在入院后第 1 天内每天接受> 2 单位 RBC 输注、输血前血红蛋白水平< 70 γ L-1或患有严重脓毒症或脓毒性休克的患者。
在研究期间共记录了 9491 次入院。通过倾向评分匹配得到了 2 个匹配良好的组,每组各有 674 例独特的患者。输血前血红蛋白中位数为 98 γ L-1(四分位距 91-107 γ L-1)。RBC 组的死亡率更高,180 天死亡率的绝对风险增加 5.9%(95%CI:3.6-8.3;P < 0.001)。低剂量 RBC 输血也与肾功能衰竭、循环衰竭和呼吸衰竭以及更高的 SOFA-max 评分相关。敏感性分析表明,两组在暴露期间的疾病轨迹没有显著差异。
给无明显贫血的非脓毒症危重症患者输注低剂量 RBC 与死亡率增加、肾功能衰竭、循环衰竭和呼吸衰竭以及更高的 SOFA-max 评分相关。